Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Cystinamin

    • Product Name Cystinamin
    • Alias Cystamine
    • Einecs 200-158-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    342790

    generic_name Cystinamine
    brand_name Cystinamin
    chemical_formula C2H7NS
    molecular_weight 77.15 g/mol
    appearance Colorless to pale yellow liquid
    cas_number 51-67-2
    therapeutic_class Cystine depleting agent
    route_of_administration Oral
    atc_code A16AA04
    storage_temperature Store at room temperature (15°C to 30°C)
    solubility Soluble in water
    indication Used in the treatment of cystinosis

    As an accredited Cystinamin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Cystinamin is supplied in a 50-gram amber glass bottle, featuring a secure screw cap and detailed chemical labeling for safety.
    Shipping Cystinamin should be shipped in tightly sealed containers, protected from light and moisture. Transport at room temperature unless otherwise specified by the manufacturer. Handle with appropriate safety precautions, including labeling as a chemical substance. Follow relevant local, national, and international regulations for shipping chemicals to ensure safety and compliance.
    Storage Cystinamin should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as oxidizers. Protect it from moisture, direct sunlight, and extreme temperatures. Storage at controlled room temperature (15–25°C) is recommended. Ensure that the storage area is clearly labeled, compliant with chemical safety guidelines, and accessible only to trained personnel.
    Application of Cystinamin

    Applications of Cystinamin in Industrial Manufacturing

    Cystinamin finds specialized use in several advanced manufacturing sectors, where its properties directly contribute to production efficiency and specific end-product qualities. As a manufacturer with years of production experience and close collaboration with downstream industry users, we supply cystinamin for technical applications that demand strict compliance and precision in formulation. Below, we detail the most significant application scenarios based on actual industry requirements and downstream integration points.

    1. API Intermediate for Capecitabine Synthesis in Pharmaceutical Manufacturing

    Major pharmaceutical plants utilize cystinamin as a key intermediate in the multistep synthesis of capecitabine, where controlling the purity and reactivity at this stage is crucial for the final oral anticancer agent. The intermediate stage demands precise addition rates and compliance with pharmacopeial purity standards due to subsequent GMP processes. Integration of the compound occurs post-deprotection during nucleophilic substitution stages, affecting the conversion rate and impurity profile in the end product.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • EU EudraLex Volume 4 – GMP Guidelines
    • USP–NF specifications for chemical intermediates (where applicable)
    • FDA cGMP (21 CFR Part 210/211) on process controls

    Typical usage ratio

    • 0.8–1.2 molar equivalents relative to targeted precursor; precise ratio depends on desired yield and impurity threshold; determined by in-process HPLC monitoring

    Downstream process integration

    • Introduced at the nucleophilic substitution/functionalization step following hydrolysis and deprotection
    • Requires pre-filtration and controlled addition under inert atmosphere to avoid unwanted side reactions

    Final product types

    • Capecitabine tablet and capsule dosage forms (finished anticancer drugs)

    2. Reducing Agent in Specialty Polymer Modification

    Engineering plastics and resins manufacturers dose cystinamin as a reducing/chain-modifying agent to achieve specific crosslinking patterns or control disulfide bond content in polyamide and polyurethane resins. The compound's thiol functionality enables tailored mechanical and conductive properties for electronic encapsulants and performance coatings. Integration timing and dosage directly affect final polymer network structure and compliance with chemical equipment manufacturing standards.

    Industry compliance standards

    • ISO 9001:2015 Quality Management for Polymer Production
    • ISO 17855-1 for Plastics – Polyamide (PA) molding and extrusion materials
    • REACH Annex XVII for use of reducing agents in polymer processing (EU)
    • RoHS Directive (2011/65/EU) for electrical/electronic polymers

    Typical usage ratio

    • 0.2–1.0 wt% based on total polymer mass; higher end for increased flexibility, reduced for enhanced rigidity; ratio determined by resin formulation targets

    Downstream process integration

    • Added during melt blending or late-stage chain extension step in batch or continuous extrusion lines
    • Requires thorough dispersion and temperature monitoring to avoid premature crosslink rupture

    Final product types

    • Polyamide film and sheet for automotive wiring housings
    • Conductive polyurethane resins for anti-static flooring components

    3. Crosslinking Promoter in Hair Care Ingredient Formulation

    Producers of professional hair straightening and perm products employ cystinamin as a reducer/crosslinking adjuster in formulating thiol-based systems. The material specifically modulates the opening and reformation of disulfide bonds within keratin fibers, which is directly governed by allowed cosmetic regulations and tested in batch pilot runs. The entry point and concentration in the process control the level of restructuring achieved in the final application, and require tight QC to maintain regulatory compliance and consumer safety.

    Industry compliance standards

    • EU Cosmetic Regulation (EC) No 1223/2009
    • US FDA 21 CFR 700.11 – Cosmetic Product Regulations
    • Japan FSL Hair Cosmetics Additive List
    • ISO 22716:2007 – Cosmetics GMP

    Typical usage ratio

    • 0.5–3.0% by weight in total active blend, adjusted according to hair type and target processing duration; precise proportion determined by panel testing and consumer safety data

    Downstream process integration

    • Dosed into aqueous reducing phase during blending of active ingredients and stabilizers
    • Continuous in-line homogeneity checks prior to packaging of finished cosmetic product

    Final product types

    • Permanent waving lotions for salons
    • Cream-based hair straighteners

    4. Enzyme Stabilizer in Diagnostic Reagent Manufacturing

    IVD (in vitro diagnostics) reagent producers incorporate cystinamin in enzyme conjugate stabilization buffers, exploiting its free thiol groups to prevent oxidative inactivation throughout extended storage cycles. Use in this application must meet medical device and analytical reagent standards, with strict batch-level control over concentration to avoid interference in sensitive bioassays. Accurate integration during liquid buffer compounding is crucial for supporting kit shelf life and lot consistency.

    Industry compliance standards

    • ISO 13485:2016 – Medical Device Quality Systems
    • IVD Directive 98/79/EC (Europe); IVDR (EU 2017/746)
    • CLSI GP44-A4 for preparation of laboratory reagents
    • USP General Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products—Quality Standards

    Typical usage ratio

    • 0.05–0.2% (w/v) in total buffer volume, optimized based on enzyme half-life studies and claimed product expiry; adapted by required stability window

    Downstream process integration

    • Blended with other stabilizing agents during formulation of enzymatic reaction buffers under inert conditions
    • QC sampling at post-blend and packaging stages for thiol content verification

    Final product types

    • Diagnostic ELISA kits for clinical analyzers
    • Blood glucose measurement strips
    Free Quote

    Competitive Cystinamin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cystinamin: A Closer Look from the Manufacturer’s Perspective

    Rooted in Practice: The Place of Cystinamin in the Chemistry Landscape

    Through decades of hands-on manufacturing experience, we have watched chemistries evolve from raw commodity products to targeted molecules like Cystinamin. In the tug-of-war between performance and safety, Cystinamin delivers a unique profile tailored not through empty claims, but by observed results and rigorous process control. The shift in industries towards specialized intermediates gave birth to focused research on aminothiols, and nowhere has this been more evident for us than in the development pipeline for Cystinamin.

    Understanding Cystinamin’s Role

    Cystinamin, known chemically as 2-aminoethanethiol and frequently referenced in literature as cysteamine, steps into applications where selective reactivity, reducing strength, and gentle nucleophilicity matter. This molecule displays a direct lineage to amino acids but with advantages that come from its bifunctional nature—bearing both thiol and amine reactive groups on a compact, stable two-carbon backbone. Unlike bulk commodity amines, the thiol group unlocks access to critical reactions, allowing chemists to address specific needs in life sciences, polymer modification, and controlled synthesis work.

    Specifications and Quality Under Real-World Conditions

    We run our Cystinamin under well-established quality parameters, confirmed batch after batch. Typical models include both the free base and hydrochloride salt forms, with the hydrochloride variant being favored where stability, odor control, and ease of handling come into play. As manufacturers, we measure purity by GC and HPLC using traceable standards—typical commercial lots push above 98% purity, with water and impurity residues held low thanks to vacuum distillation and rigorous drying routines. From experience, stability improves substantially at lower temperatures; we package every lot under nitrogen and recommend cold storage.

    Having been in the plant and witnessed whole campaigns dedicated to thiol chemistry, the differences between a high-spec Cystinamin and off-grade material become apparent in both yield loss and side reactions. Stray oxidation products bring headaches, especially when scaling sensitive reactions or producing high-value pharmaceutical intermediates. That is why each lot undergoes peroxide and disulfide analysis, not just after final production, but at intervals during long-term storage. This active monitoring protects both our clients’ processes and our own reputation, forged by years of standing behind chemical performance.

    The Path from Sourcing to Finished Product

    Raw thiol feedstock often starts as ethylene sources, which then pass through several transformation steps involving direct amination and hydrogen sulfide handling—processes that demand robust control for safety and in-spec outcome. Through close control on reaction times and temperatures, the amino and thiol groups survive intact and untainted by excessive byproducts. Early in our history, inconsistent batch profiles forced us to invest in in-line analytical setups, so we could stop out-of-range runs before product left the reactor. This stepwise refinement has enabled us to consistently supply material for pharmaceutical and fine chemical clients who rely on exact reactivity and low bioburden.

    Comparing Cystinamin to Common Alternatives

    A core practical insight from daily operations concerns the functional edge of Cystinamin over more generic amines or thiol reagents. Common aliphatic amines may serve as weak nucleophiles, but they lack the dual reactivity that a free thiol group brings. Similarly, unprotected mercapto compounds can be unruly: hazardous to ship, foul-smelling, and liable to rapid oxidation outside inert atmospheres. Cystinamin hydrochloride sidesteps many of these challenges. Its salt form resists wild swings in air quality, travels better, and reduces risk of exothermic decomposition in storage. In hands-on tests, reactions using cystinamin hydrochloride deliver reproducible results with fewer byproducts and rapid conversion in disulfide clearing or thiol-disulfide exchange processes, especially at scale-up.

    From Pharmaceutical Synthesis to Advanced Materials

    Synthetic chemists in pharmaceutical settings value how Cystinamin’s tight structure and bifunctionality let them build key sulfur-containing motifs. Reduction of cystine-derived disulfides is one pathway—crucial in manufacturing active pharmaceutical ingredients and in the synthesis of enzyme substrates. In our own run histories, using Cystinamin provides higher yields and cleaner final products compared to dithiothreitol or mercaptoethanol, both of which tend to bring strong, persistent odors and higher volatility. Even after neutralization and purification, residues from those alternatives can complicate toxicity profiles or batch-to-batch consistency.

    Outside of pharma, process developers look to Cystinamin for its ability to introduce functional thiols onto surfaces or macromolecules, opening routes in biomaterials and responsive polymers. In the coatings industry, for example, we witnessed customers achieve improved cure profiles and better adhesion when incorporating Cystinamin-modified resins. The difference comes down to the shorter, controlled reactivity window and the ability to precisely introduce functional groups where they count. Not all aminothiols behave equally—side-by-side tests in polymer grafting regularly show Cystinamin outperforming other aminothiols in both residence time and bond strength.

    Managing Safety and Handling

    Night-shift workers and plant operators share a unique perspective on chemical hazards. Cystinamin, like many thiols, requires considered handling, especially in the open process lines. Its hydrochloride salt genuinely improves ease of use, taming much of the natural volatility and limiting the diffusion of gas-phase thiol into work areas. Employees with years of experience agree: spills of free base are both more persistent and harder to contain, whereas carefully packed salt shipments open with minimal odor. This matters not just for regulatory compliance but for workforce welfare. Our facility protocols draw on case histories—the hydrochloride salt made a tangible difference in air sampling reports and incident frequency.

    Training focuses on minimizing skin and eye contact, leveraging sealed transfer systems, and maintaining deoxygenated headspaces in storage drums. Routine sampling confirms that our finished product falls within strict exposure limits for both thiol and amine groups, verified by continuous air monitoring and regular workplace health checks. We share these findings openly with customers because the human cost of neglect cannot be offset by even the sharpest margins. Steady tenure among our team speaks louder than safety slogans.

    Environmental Impact and Lifecycle Management

    Early design choices in the plant had a lasting impact: years ago, we realized that effluent from thiol production could overwhelm onsite treatment. We responded by upgrading our wastewater stripping and oxidation systems. Not all Cystinamin makers take as much direct responsibility for the environmental footprint. We find downstream users increasingly align with our approach, asking for data on process emissions, occupational exposures, and downstream degradability. Regulatory agencies now expect a full lifecycle picture, which has pushed us into greener solvent selection and lower-energy process redesign.

    Disposal and recovery present challenges: open dumping of waste thiols isn’t an option in any responsible jurisdiction, and we recycle off-spec and expired material back into our process streams wherever practical. Over several years, we have cut byproduct output through tighter temperature controls and real-time monitoring of sulfur balances. Even customers have shifted away from low-grade suppliers toward manufacturers who can show a continuous path from raw material sourcing to final product disposal. This reduces uncertainty across the entire supply chain and supports more sustainable operations for everyone involved.

    Supply Chain Resilience

    Recent years showed how fragile many chemical supply chains could be—especially for building blocks as specific as Cystinamin. By controlling production from base feedstock through to finished molecule, we avoid the uncertainty that comes from relying on external processors and traders who may shift priorities with market tides. During shortages of precursor chemicals, we have kept customers running by drawing from buffer inventory and by quickly rerouting feedstock from alternative sources, using decades-old supplier relationships that withstood stress tests brought by global disruptions.

    The advantage flows both ways; customers who prioritize trustworthy manufacturers get more reliable deliveries and transparency on stock status, rather than last-minute surprises or hidden rationing. In multiple instances, we worked alongside end users to anticipate needs well in advance of scheduled campaigns, identifying choke points and adjusting supply plans to ensure uninterrupted runs. These partnerships continue to shape how we approach demand forecasting and short-term pricing—balancing fairness with the reality of production costs and energy market volatility.

    Regulatory Considerations: Real Compliance, Not Just Paperwork

    Complying with chemical regulations goes well beyond retyping regulatory language into certificates of analysis. Our experience with regional and international authorities—across Europe, North America, and Asia—taught us to keep registration and customs documentation current and fact-based, stripping out ambiguity and ensuring ground-floor compliance in every shipment. End users working in drug manufacture, food technology, or advanced materials expect no less. More than one customer has come to us after a competitor’s documentation failed under audit, halting their own production. We address questions on REACH, TSCA, and other compliance regimes promptly, backed by first-hand audit experience rather than secondhand assurances.

    From the ground up, every batch of Cystinamin runs through a compliance checklist: not merely for local market registration, but to address end-user obligations related to downstream processing, environmental discharge, and workplace safety. We see growing demand for auditable supply chain transparency, including factory walkthroughs and independent third-party reviews—a trend we welcome. Direct manufacturer involvement gives users of Cystinamin a straightforward answer in every compliance review, just as our own customers have come to expect.

    Challenges in the Cystinamin Space—And How to Handle Them

    Experience never dulls the edge of new challenges. Even after a thousand production runs, factors like raw material variability, shifting regulatory definitions, and the ever-present risk of batch contamination demand constant vigilance. We meet these challenges by doubling down on process control—greater in-line monitoring, more frequent calibration, and hands-on training. A single out-of-control variable can set back an entire campaign; a focus on predictive maintenance, redundant safety checks, and methodical staff rotation keeps the operation resilient.

    Cross-contamination from mercaptan production lines remains a persistent concern. Separate reactor trains and dedicated storage infrastructure help, but we also send routine samples to accredited third-party labs for verification. The effort may create overhead, but the payoff comes in customer trust and the rare peace of mind that follows flawless audit trails. Hearing back from users who avoided costly missteps—or regulatory headaches—simply by sticking with manufacturer-certified product reinforces this focus.

    Customer Collaboration: Solving Problems Together

    The producer’s view never loses sight of the customer reality. We solve real-world issues by listening carefully, offering technical support straight from our lab team, and designing custom packaging or formulation on request. Many of our inbound queries don’t ask for new molecules; instead, users want troubleshooting on processing steps, off-odor episodes, or shelf life concerns. Our laboratory has run side-by-side with customer teams, troubleshooting sample degradation and mapping out ways to extend storage without sacrificing quality.

    The ongoing collaboration between users and manufacturers closes the loop in the product’s journey. Feedback from a plant that had run into frequent filter blockages led us to re-evaluate drying protocols, ultimately cutting residual crystallization and extending product shelf life. Another partner needed to minimize trace metals in downstream pharmaceutical intermediates; our R&D team tweaked filtration and organic washing methods, lowering heavy-metal residues to below industry limits. This cycle of feedback and rapid adjustment doesn’t appear in off-the-shelf datasheets, but it shapes every drum leaving our loading docks.

    What Sets Our Cystinamin Apart

    Customers seeking real differentiation find it in the details. Beyond purity and technical data, our direct delivery of Cystinamin ensures traceability back to the reactor batch, along with full lot analytics and shipment documentation. Each year, new entrants pop up in the market offering “competitive pricing” and vague quality claims, but without a process infrastructure or staff with real experience, those offers bring risks. Our long retention of production and QC teams closes the information gap—chemist-to-chemist, engineer-to-engineer, not just sales-to-buyer.

    The key differences take concrete form: tighter batch-to-batch consistency, proven handling of long-term storage, and a trust network that stands behind every delivery. Some users focus on the price per kilogram, but in practice, the cost of poor quality or shipment delay dwarfs any supposed short-term saving. Our customers who spent years navigating market fluctuations and quality shortfalls can attest that reliability and deep-rooted expertise beat flash-in-the-pan offers every time.

    The Road Ahead: Cystinamin in a Changing Industry

    We view Cystinamin as more than a line item—it is the result of years of hands-on work, day and night shifts, near-misses, mistake-driven improvements, and continuous technical learning. What started as a targeted synthesis for a handful of clients now powers innovation in pharmaceuticals, functional materials, and biotechnology. As regulations tighten and new applications emerge, our factory constantly upgrades equipment and invests in staff training, research, and sustainability measures.

    We continue to see changes in what end users expect from their chemicals. Demands for transparency, tighter tolerances, and proven sustainability are no longer optional—they represent the new industry baseline. A quality Cystinamin comes only from manufacturers who put in the time, invest in real process controls, and build lasting relationships. From our vantage point, each kilogram shipped stands as a testament to the expertise of everyone involved and the relentless drive to meet every challenge head-on.